Precore mutation of hepatitis B virus may be associated with low breakthrough rate following long-term lamivudine therapy in patients with chronic hepatitis B

被引：0
|
作者：
Ryu, SH [1 ]
Chung, YH [1 ]
Choi, MH [1 ]
Kim, JA [1 ]
Shin, JW [1 ]
Jang, MK [1 ]
Park, NH [1 ]
Lee, HC [1 ]
Lee, YS [1 ]
Suh, DJ [1 ]
机构：
[1] Univ Ulsan, Coll Med, Asan Med Ctr, Seoul, South Korea
来源：
HEPATOLOGY | 2002年 / 36卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1917
引用
收藏
页码：642A / 642A
页数：1
相关论文
共 50 条
  • [1] Precore stop codon mutation of hepatitis B virus is associated with low breakthrough rate following long-term lamivudine therapy
    Shin, JW
    Chung, YH
    Choi, MH
    Kim, JA
    Ryu, SH
    Jang, MK
    Kim, IS
    Park, NH
    Lee, HC
    Lee, YS
    Suh, DJ
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2005, 20 (06) : 844 - 849
  • [2] Polymerase domain B mutation is associated with hepatitis relapse during long-term lamivudine therapy for chronic hepatitis B
    Nakanishi, H
    Kurosaki, M
    Asahina, Y
    Onuki, Y
    Ueda, K
    Nishimura, Y
    Tsuchiya, K
    Kitamura, T
    Uchihara, M
    Miyake, S
    Enomoto, N
    Izumi, N
    INTERVIROLOGY, 2005, 48 (06) : 381 - 388
  • [3] Long-term lamivudine therapy in chronic hepatitis B
    Lingala, S.
    Lau, D. T. -Y.
    Koh, C.
    Auh, S.
    Ghany, M. G.
    Hoofnagle, J. H.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2016, 44 (04) : 380 - 389
  • [4] Long-term therapy of chronic hepatitis B with lamivudine
    Lu, DTY
    Khokhar, MF
    Doo, E
    Ghany, MG
    Herion, D
    Park, Y
    Kleiner, DE
    Schmid, P
    Condreay, LD
    Gauthier, J
    Kuhns, MC
    Liang, TJ
    Hoofnagle, JH
    HEPATOLOGY, 2000, 32 (04) : 828 - 834
  • [5] Hepatitis B virus mutations associated with lamivudine therapy in patients with chronic hepatitis B
    Asahina, Y
    Enomoto, N
    Nagayama, K
    Kurosaki, M
    Ogura, Y
    Izumi, N
    Marumo, F
    Sato, C
    HEPATOLOGY RESEARCH, 1999, 15 (02) : 145 - 156
  • [6] Emergence of YMDD mutants during long-term lamivudine therapy may not cause breakthrough in patients with chronic hepatitis B.
    Jung, SA
    Chung, YH
    Yang, SH
    Song, BC
    Chung, SW
    Lee, SS
    Jang, WY
    Choi, MH
    Lee, HC
    Lee, YS
    Suh, DJ
    HEPATOLOGY, 2000, 32 (04) : 583A - 583A
  • [7] Prognostic factors that associated with hepatitis B virus DNA breakthrough in chronic hepatitis B patients with lamivudine treatment
    Zeng, Zheng
    Tian, Guobao
    Tian, Di
    Cui, Jianjun
    Lu, Haiying
    HEPATOLOGY, 2007, 46 (04) : 683A - 683A
  • [8] Evolution of hepatitis B virus during long-term therapy in patients with chronic hepatitis B
    Arrese, Elisabete
    Basaras, Miren
    Blanco, Sonia
    Ruiz, Pablo
    Cisterna, Ramon
    ANNALS OF HEPATOLOGY, 2011, 10 (04) : 434 - 440
  • [9] Long-term lamivudine therapy for chronic hepatitis B in patients with and without cirrhosis
    Oh, JM
    Kyun, J
    Cho, SW
    PHARMACOTHERAPY, 2002, 22 (10): : 1226 - 1234
  • [10] Association of core promoter mutations with viral breakthrough in chronic hepatitis B patients on long-term lamivudine therapy
    Kazim, Syed Naqui
    Chauhan, Ranjit
    Das, Bhudev Chandra
    Sarin, Shiv Kumar
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2006, 21 (10) : 1525 - 1532
12345